Global Markets for 3D Cultures and Organoids: Trends Analysis with Forecast
“The market for lab models, 3D cultures, and organoids is rapidly growing, driven by new technology and the need for alternatives to animal testing in research.”... Read more.
AM Best Withdraws Credit Ratings of Newpoint Reinsurance Company Limited
LONDON–(BUSINESS WIRE)–AM Best has withdrawn the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of “bbb-” (Good) of... Read more.
WSI® Unveils its New Order Fulfillment Brand, Kase™, a True Omnichannel 3PL
Complete omnichannel fulfillment solutions for today’s multichannel retailer APPLETON, Wis., March 12, 2025 /PRNewswire/ — WSI® (Warehouse Specialists,... Read more.
OKX Europe Enhances Institutional Offering, Announces MiFID II License Acquisition at Exclusive Event in Malta
VALLETTA, Malta, March 12, 2025 /PRNewswire/ — OKX, a leading global blockchain technology company, today announced its strategic acquisition of a Markets... Read more.
The ADDF’s Diagnostics Accelerator Authors New Paper on Ocular Biomarker Landscape, Highlighting Ocular Tests as a Tool for Early Detection of Alzheimer’s Disease
New findings published in Alzheimer’s & Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer’s,... Read more.
Hello Kitty Island Adventure Sells Over Half a Million in 30 Days
Players Catapult Game and Independent Studio ‘Sunblink’ to a Smash Hit; Pre-orders for Physical Release Open Now BOULDER, Colo.–(BUSINESS WIRE)–Hello... Read more.
G2’s New Innovations Help Software Vendors Reach More Buyers
World’s largest software marketplace unveils syndication partnership with Ramp and new tools for review generation and collection CHICAGO–(BUSINESS WIRE)–G2... Read more.
AM Best Affirms Credit Ratings for Members of GuideOne Insurance Companies
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term... Read more.
Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome
FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome... Read more.
Marsh McLennan Declares Quarterly Cash Dividend
NEW YORK–(BUSINESS WIRE)–The Board of Directors of Marsh McLennan (NYSE: MMC) today declared a quarterly dividend of $0.815 per share on outstanding... Read more.